Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma

Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma

Background Circulating tumor DNA (ctDNA) is a biomarker for the selection of target agents in various malignancies. In this study, we examined the effect of ctDNA presence on the response to EGFR‐tyrosine kinase inhibitor (TKI) and on the prognosis in lung adenocarcinoma. Methods ctDNA of EGFR‐TKI s...

Full description

Bibliographic Details
Main Authors: Taehee Kim, Eun Young Kim, Sang Hoon Lee, Do Sun Kwon, Arum Kim, Yoon Soo Chang
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Thoracic Cancer
Subjects:
ctDNA
ddPCR
lung adenocarcinoma
mEGFR
Online Access:https://doi.org/10.1111/1759-7714.13219

Similar Items

Similar Items